Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Omnicare reaffirms FY 2014 guidance


Tuesday, 25 Mar 2014 07:30am EDT 

Omnicare Inc:Reaffirms expected FY 2014 guidance from continuing operations.Expects FY 2014 revenue of $6.3 bln to $6.4 bln.Expects FY 2014 adjusted cash earnings per diluted share (excluding special items) of $3.64 to $3.72.FY 2014 revenue of $6.36 bln and EPS of $3.69 - Thomson Reuters I/B/E/S. 

Company Quote

76.48
 --
26 Jan 2015